Abel Martel Martel
@abelmartel.bsky.social
PhD || Postdoctoral Fellow at
@mdanderson.bsky.social, Clinical Cancer Prevention || #LynchSyndrome, #EOCRC, #ColorectalCancer || 🇮🇨🇪🇸🏡
@mdanderson.bsky.social, Clinical Cancer Prevention || #LynchSyndrome, #EOCRC, #ColorectalCancer || 🇮🇨🇪🇸🏡
Happy to attend the 3rd Annual James P. Allison Institute Scientific Symposium — a fantastic opportunity to exchange ideas in immunology and cancer research. Grateful for the insights shared by distinguished leaders in the field, including five Nobel Laureates.
@mdanderson.bsky.social
@mdanderson.bsky.social
October 24, 2025 at 11:12 PM
Happy to attend the 3rd Annual James P. Allison Institute Scientific Symposium — a fantastic opportunity to exchange ideas in immunology and cancer research. Grateful for the insights shared by distinguished leaders in the field, including five Nobel Laureates.
@mdanderson.bsky.social
@mdanderson.bsky.social
Happy to present at #AACR25 @theaacr.bsky.social our work on the interception of FAP-associated colorectal cancer through WNT/β-catenin pathway modulation. Proud to share our research from @mdanderson.bsky.social!
April 28, 2025 at 4:30 PM
Happy to present at #AACR25 @theaacr.bsky.social our work on the interception of FAP-associated colorectal cancer through WNT/β-catenin pathway modulation. Proud to share our research from @mdanderson.bsky.social!
Just landed in Chicago for #AACR25! Ready to connect, share science, and strengthen our cancer research community @mdanderson.bsky.social, @theaacr.bsky.social!
April 27, 2025 at 10:09 PM
Just landed in Chicago for #AACR25! Ready to connect, share science, and strengthen our cancer research community @mdanderson.bsky.social, @theaacr.bsky.social!
Just released our latest comprehensive review on neoantigen vaccines in cancer prevention. @mdanderson.bsky.social
Neoantigen Vaccines in Cancer Prevention : The Cancer Journal
distinctive feature promotes robust immune responses while reducing the risk of autoimmune side effects. Developing standardized “off-the-shelf” vaccines targeting shared neoantigens offers a scalable...
journals.lww.com
March 25, 2025 at 11:55 PM
Just released our latest comprehensive review on neoantigen vaccines in cancer prevention. @mdanderson.bsky.social
Reposted by Abel Martel Martel
👏 Some valuable #CRC #LynchSyndrome research being published w/ #ColorectalCancerAwarenessMonth starting in March. A shout out to our member Dr Eduardo Vilar!
#HereditaryGICancer
@aliveandkickn.bsky.social @lsireland.bsky.social @lynchsyndromeuk.bsky.social @lineageconsortium.bsky.social
#HereditaryGICancer
@aliveandkickn.bsky.social @lsireland.bsky.social @lynchsyndromeuk.bsky.social @lineageconsortium.bsky.social
Just released our latest work in @jci-insight.bsky.social, @mdanderson.bsky.social - Inhibition of histone methyltransferase EZH2 for immune-interception of colorectal cancer in Lynch syndrome. insight.jci.org/articles/vie...
insight.jci.org
February 14, 2025 at 11:45 PM
👏 Some valuable #CRC #LynchSyndrome research being published w/ #ColorectalCancerAwarenessMonth starting in March. A shout out to our member Dr Eduardo Vilar!
#HereditaryGICancer
@aliveandkickn.bsky.social @lsireland.bsky.social @lynchsyndromeuk.bsky.social @lineageconsortium.bsky.social
#HereditaryGICancer
@aliveandkickn.bsky.social @lsireland.bsky.social @lynchsyndromeuk.bsky.social @lineageconsortium.bsky.social
Just released our latest work in @jci-insight.bsky.social, @mdanderson.bsky.social - Inhibition of histone methyltransferase EZH2 for immune-interception of colorectal cancer in Lynch syndrome. insight.jci.org/articles/vie...
insight.jci.org
February 13, 2025 at 7:39 PM
Just released our latest work in @jci-insight.bsky.social, @mdanderson.bsky.social - Inhibition of histone methyltransferase EZH2 for immune-interception of colorectal cancer in Lynch syndrome. insight.jci.org/articles/vie...